Dysgen (™) is already available for Labrador Retriever - Joint and digestive care for pets

Español | English

Home | Bioiberica People | Site Map | Contact

Pharma - Osteoarthritis

Partnering & Licensing

Pets links

Goodogs
Quality and yummy flavour of Goodogs

Bioibérica - Veterinary
The website of the Veterinary division

Salud Mascotas
The website for the health of your pet

Última actualización:
24 de mayo de 2013

Dysgen (™) is already available for Labrador Retriever

Dysgen, now available for Labrador Retriever

Dysgen™ is a DNA chip developed by Bioibérica S.A that assesses the genetic predisposition of a dog to develop Canine Hip Dysplasia (CHD) by means of a blood sample

What’s Dysgen™?

Dysgen® is a liquid DNA bead chip that simultaneously detects 7 genetic markers associated with CHD. Thus, it is able to determine the genetic predisposition of pure-breed Labrador Retriever to develop this disease.

The technology allows for the dog’s DNA to be collected by means of a simple blood sample in order to detect the genetic markers of interest.

What are the clinical benefits of Dysgen™?

EARLY DETECTION

Dysgen™ makes possible to assess the genetic predisposition to develop CHD before the onset of the first signs, since it can be performed during the first weeks of the dog’s life. This information is essential to:

a) Identify those dogs with a high probability of being free of CHD and select them as dam and sire.

b) Genetic information will allow to establish an optimum follow-up schedule and take preventive measures and thus to delay and/or minimize the development of this pathology.

PERSONALIZED MEDICINE

Knowing a dog’s genetic predisposition to develop CHD allows for personalized treatment based on each dog’s risk level. It is, making specific medical and surgical decisions regarding each animal with greater certainty.

What kind of information do I receive? How results should be understood?

Dysgen^™ report indicates whether a dog is a carrier of the risk variant of each of the genetic markers analysed and, using a predictive mathematical model that takes into account all of the marker information, it classifies the animal into a risk group for developing CHD (minimal, low, moderate, high).

Genetic predisposition of dysplasia

Troy’s genetic predisposition to develop CHD is MINIMAL. Only 3% of dogs at this risk group presented CHD, it is 6.7 times lower risk than the mean of the general population. There is a high probability its joint conformation to be normal and CHD do not be developed.

If you need further information or you are interested in asking for an analysis, please contact with our area manager.

White paper on Dysgen

In the white paper on Dysgen, a group of veterinarians specializing in trauma, orthopedic surgery and rehabilitation offer clinical practice advice based on the first results of the Dysgen test for growing dogs. Dysgen is a DNA chip test that predicts the risk of developing hip dysplasia from a blood sample.

The information collected by this paper will help veterinarians to establish individualized follow-on procedures adapted to the genetic predisposition of each individual, and to take the right decisions to improve the treatment of those animals at risk of developing hip dysplasia.

Logically, recommendations deducted from this white paper should be interpreted taking into account the clinical history of every patient. The Dysgen white paper aims also at improving advice to dog owners about the possible future evolution of their dog’s disease.

Please click here to read the Dysgen white paper